Skip to main content
Middle East Current Psychiatry
Fig. 4 | Middle East Current Psychiatry

Fig. 4

From: Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries

Fig. 4

Example of patient pathway when starting treatment of TRD with esketamine nasal spray. Figure adapted from Kasper S, et al. 2021 [11]. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way

MDD major depressive disorder, SNRI serotonin and norepinephrine reuptake inhibitor, SSRI selective serotonin reuptake inhibitor, TRD treatment-resistant depression

Back to article page